Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7376 p633
19 November 2005

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· The Guild (2)
· Gender
· Prescriptions
· Medicines use reviews (3)
· Supervision (2)
· Skin cancer
· North East London LPC
· Birdsgrove House
· The Society (2)


Letters to the Editor

Skin cancer

Moderate sunbathing would seem to be healthy

From Mr J. B. Paige, MRPharmS

The debate on the risk/benefit ratio of exposure to sunlight, reported in the PJ of 12 November (p613) fascinated me. For years I have wondered if the standard advice to avoid exposure to sunlight as much as possible might be misguided.

Our view of attractiveness in others often seems to be based on an instinctive measure of health and fitness. Most people would agree that a person with no tan looks unhealthy, someone with a partial tan looks well and the person who has tanned to the limit or has been burned by the sun looks unattractive. Instinct seems to tell us that it is healthy to have some exposure to tanning UV radiation but unhealthy to have too little or too much.

If exposure to UV radiation were harmful to health it would be difficult to explain why Homo sapiens evolved pale skin as the species migrated away from the tropics. Pale skin allows greater absorption of UV light and it seems unlikely that such rapid evolution of paler skin could be accounted for solely by a reduced risk of rickets. That skin colour should correlate so closely to latitude and to recent sun exposure appears to indicate that the human body needs a fairly precise dose of UV exposure to thrive.

Northern Europeans cover themselves with clothes and spend most of their time out of the sunlight. As a result their UV exposure is far lower than that for which their skin has evolved. Moderate sunbathing would therefore seem to be healthy, if not essential.

J. Barrie Paige
Guernsey, Channel Islands

Send your letter to The Editor

Previous Topic (Supervision)
Next Topic (North East London LPC)

Back to Top


©The Pharmaceutical Journal